A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Radiopharm Theranostics, Ltd
Terremoto Biosciences Inc.
Ensem Therapeutics
PMV Pharmaceuticals, Inc
Eli Lilly and Company
Arvinas Inc.
Perspective Therapeutics
Second Life Therapeutics
Ocellaris Pharma, Inc.
Tanabe Pharma America, Inc.
BicycleTx Limited
Shasqi, Inc.
Maastricht University Medical Center
LigaChem Biosciences, Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
Incyte Corporation
Medicenna Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
OncoC4, Inc.
Numab Therapeutics AG
Portage Biotech
Purple Biotech Ltd.
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
NextCure, Inc.
NGM Biopharmaceuticals, Inc
Cancer Research UK
NantCell, Inc.
Compugen Ltd
Second Affiliated Hospital of Guangzhou Medical University
Innolake Biopharm
CytomX Therapeutics
Fusion Pharmaceuticals Inc.
Klus Pharma Inc.
Genmab
Kineta Inc.
Incyte Corporation
Incyte Corporation
Seagen Inc.
Incyte Corporation
NKGen Biotech, Inc.
Lumos Pharma
Daiichi Sankyo
Otsuka Novel Products GmbH
Centocor, Inc.
Memorial Sloan Kettering Cancer Center
Duke University